72°

Topics

GlaxoSmithKline PLC
Former head of GlaxoSmithKline in China is accused of bribery
Former head of GlaxoSmithKline in China is accused of bribery

The former head of GlaxoSmithKline in China was charged with corruption by local authorities after a probe that resulted in accusations that the drug maker ran a wide-ranging bribery scheme that included payoffs to doctors. Chinese police alleged that William Mark Reilly, once the top executive for the British pharmaceutical company in China, pushed his team "to bribe hospitals, doctors and health institutions through various means," the official Xinhua news agency reported. Reilly and two other Chinese executives are also suspected of bribing government officials in Shanghai and Beijing, the report said. Police have wrapped up their investigation into GlaxoSmithKline and...

Loading